Below are the earnings highlights for Ligand Pharmaceuticals Inc (LGND):
Earnings: -$7.17 million in Q3 vs. -$10.27 million in the same period last year.
EPS: -$0.39 in Q3 vs. -$0.59 in the same period last year.
Excluding items, Ligand Pharmaceuticals Inc reported adjusted earnings of $35.32 million or $1.84 per share for the period.
Analysts projected $1.35 per share
Revenue: $51.81 million in Q3 vs. $32.87 million in the same period last year.
-Guidance:
Full year EPS guidance: $5.50 - $5.70
Full year revenue guidance: $160 - $165 Mln
For comments and feedback: editorial@rttnews.com